Title | Total cells | ||
1 | A blood atlas of COVID-19 defines hallmarks of disease severity and specificity Dataset 1: COMBAT project: single cell gene expression data from COVID-19, sepsis and flu patient PBMCs cell type: NK.CD16hi NK.CD16int expressed genes: NADSYN1 | ||
2 | A human fetal lung cell atlas uncovers proximal-distal gradients of differentiation and key regulators of epithelial fates Dataset 1: All cells cell type: CD16-positive, CD56-dim natural killer cell, human expressed genes: NADSYN1 | ||
3 | Cross-tissue immune cell analysis reveals tissue-specific features in humans Dataset 1: Global cell type: NK_CD16+ expressed genes: NADSYN1 | ||
4 | Local and systemic responses to SARS-CoV-2 infection in children and adults Dataset 2: Airway cell type: NK cd56lo expressed genes: NADSYN1 | ||
5 | Single-cell multi-omics analysis of the immune response in COVID-19 Dataset 1: Single-cell multi-omics analysis of the immune response in COVID-19 cell type: NK_16hi expressed genes: NADSYN1 | ||
6 | Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell–like blasts in KMT2A-rearranged leukemia Dataset 1: Global dataset of infant KMT2Ar B-ALL cell type: CD16_NK expressed genes: NADSYN1 | ||
7 | Time-resolved Systems Immunology Reveals a Late Juncture Linked to Fatal COVID-19 Dataset 2: Time-resolved Systems Immunology Reveals a Late Juncture Linked to Fatal COVID-19: Innate Cells cell type: NK_CD16hi expressed genes: NADSYN1 | ||
8 | Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19 Dataset 1: Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19 cell type: NK_CD16+ expressed genes: NADSYN1 |